Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
Ticker SymbolTKNO
Company nameAlpha Teknova Inc
IPO dateJun 25, 2021
CEOMr. Stephen Gunstream
Number of employees173
Security typeOrdinary Share
Fiscal year-endJun 25
Address2451 Bert Drive
CityHOLLISTER
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code95023
Phone18316371100
Websitehttps://www.teknova.com/
Ticker SymbolTKNO
IPO dateJun 25, 2021
CEOMr. Stephen Gunstream
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data